CN116042558A - Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof - Google Patents
Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof Download PDFInfo
- Publication number
- CN116042558A CN116042558A CN202211721650.6A CN202211721650A CN116042558A CN 116042558 A CN116042558 A CN 116042558A CN 202211721650 A CN202211721650 A CN 202211721650A CN 116042558 A CN116042558 A CN 116042558A
- Authority
- CN
- China
- Prior art keywords
- ketone reductase
- akrh
- degradation agent
- mutant
- aldehyde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000015556 catabolic process Effects 0.000 title claims abstract description 51
- 238000006731 degradation reaction Methods 0.000 title claims abstract description 51
- 150000001299 aldehydes Chemical class 0.000 title claims abstract description 26
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 title claims abstract description 25
- 102000005751 Alcohol Oxidoreductases Human genes 0.000 title claims abstract description 25
- 239000000284 extract Substances 0.000 title claims abstract description 14
- 241000208689 Eucommia ulmoides Species 0.000 title claims abstract 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 claims abstract description 25
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 13
- 241000894006 Bacteria Species 0.000 claims abstract description 12
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052901 montmorillonite Inorganic materials 0.000 claims abstract description 9
- 241000499912 Trichoderma reesei Species 0.000 claims abstract description 8
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 6
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 10
- 150000001413 amino acids Chemical group 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 235000005822 corn Nutrition 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 5
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 230000000593 degrading effect Effects 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 235000015099 wheat brans Nutrition 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Chemical group CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 241000235058 Komagataella pastoris Species 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical group OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 101710089042 Demethyl-4-deoxygadusol synthase Proteins 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 9
- 238000012216 screening Methods 0.000 abstract description 7
- 230000035772 mutation Effects 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 5
- 231100000765 toxin Toxicity 0.000 abstract description 5
- 241001465754 Metazoa Species 0.000 abstract description 4
- 231100000678 Mycotoxin Toxicity 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 4
- 239000002636 mycotoxin Substances 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 3
- 210000004916 vomit Anatomy 0.000 abstract description 3
- 230000008673 vomiting Effects 0.000 abstract description 3
- 239000003463 adsorbent Substances 0.000 abstract description 2
- 239000003674 animal food additive Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- 244000237330 gutta percha tree Species 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000000123 paper Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920000298 Cellophane Polymers 0.000 description 2
- 241000223195 Fusarium graminearum Species 0.000 description 2
- 102000004317 Lyases Human genes 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102220482680 Uncharacterized protein EXOC3-AS1_Q64D_mutation Human genes 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 2
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011086 glassine Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 1
- 241000237525 Mytilidae Species 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229930002954 deoxynivalenol Natural products 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229930013292 trichothecene Natural products 0.000 description 1
- LZAJKCZTKKKZNT-PMNGPLLRSA-N trichothecene Chemical compound C12([C@@]3(CC[C@H]2OC2C=C(CCC23C)C)C)CO1 LZAJKCZTKKKZNT-PMNGPLLRSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/84—Pichia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/885—Trichoderma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
The invention provides a degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof. The invention makes mutation on aldehyde-ketone reductase from methyl capsule a sp, constructs mutant library, uses Trichoderma reesei as expression host, and obtains aldehyde-ketone reductase mutant AkrH with obviously improved vomit toxin degradation effect through screening. The mutant AkrH has an approximately 3-fold increase in the level of degradation of vomitoxin compared to the original gene. The degradation agent prepared by compounding the spray dried powder prepared by the recombinant bacteria containing the aldehyde ketone reductase mutant AkrH, the eucommia ulmoides leaf extract, the montmorillonite powder and other adsorbents can degrade vomit toxin in feed raw materials to more than 95 percent on average, has good application prospect in the fields of preventing mycotoxin, grains, feed additives and the like, and is beneficial to animal cultivation.
Description
Technical Field
The invention belongs to the field of enzyme engineering, and in particular relates to a degradation agent containing aldehyde ketone reductase mutants and eucommia ulmoides leaf extracts and application thereof.
Background
Vomitoxin, also known as deoxynivalenol toxin (DON), is a B-type trichothecene toxin, and is a secondary metabolite produced mainly by Fusarium graminearum (Fusarium graminearum) and Fusarium flavum (Fusarium culmorum), which easily contaminates grains and feeds. Vomitoxin can seriously affect the yield and quality of grains, can generate strong stimulation and reflection on the mucous membrane of the digestive tract of animals after entering a food chain to act on vomit centers, and affects the production performance, immune cell proliferation, apoptosis and the generation of immune cytokines, and has cytotoxicity. The ingestion of certain amounts of grains contaminated with DON by humans and animals poses a serious threat to their health, and research into the control of DON is therefore urgent.
The prior detoxification methods of DON mainly comprise a physical method, a chemical method and a biological degradation method. However, the structure of DON is very stable, the detoxification effect of physical method is not ideal, while the chemical treatment method can achieve better detoxification effect, but introduces other harmful substances and causes nutrition loss of grains, while the biodegradation method is to degrade mycotoxin under mild conditions by screening microorganisms in nature, convert DON into non-toxic or low-toxic substances and can not cause nutrition loss. Biodegradation is therefore considered to be the best method for removing mycotoxins.
Disclosure of Invention
The invention provides a degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof. The mutant AkrH with obviously improved vomitoxin degradation effect is obtained through screening, and can obviously degrade vomitoxin in feed raw materials with a degradation agent prepared from eucommia ulmoides leaf extract, montmorillonite powder and the like.
In order to achieve the aim of the invention, the invention is realized by adopting the following technical scheme:
the invention provides an aldehyde ketone reductase mutant AkrH, the amino acid sequence of which is shown in SEQ ID NO: 3.
Further: the aldehyde ketone reductase mutant AkrH consists of a sequence of amino acid SEQ ID NO:1, from which glutamine at position 64 of the aldehyde-ketone reductase was changed to aspartic acid, leucine at position 131 was changed to serine, and leucine at position 212 was changed to valine.
The invention provides a coding gene of the aldehyde ketone reductase mutant AkrH, and the nucleotide sequence of the coding gene is shown as SEQ ID NO: 4.
The invention provides a recombinant expression vector containing the coding gene.
The invention provides a recombinant bacterium containing the coding gene, wherein the recombinant bacterium is bacillus subtilis, trichoderma reesei or pichia pastoris.
The invention provides a degradation agent, which comprises aldehyde ketone reductase mutant AkrH, eucommia ulmoides leaf extract, montmorillonite powder, glucose oxidase and bacillus subtilis.
Further: the degradation agent comprises 55% -70% of aldehyde ketone reductase mutant AkrH,8% -10% of montmorillonite powder, 0.1% -3% of glucose oxidase, 1% -3% of bacillus subtilis and the balance of eucommia ulmoides leaf extract by weight.
The invention provides application of the degradation agent in degrading vomitoxin in feed raw materials.
Further: the dosage of the degradation agent is 0.1% -0.5% of the weight of the feed raw material.
Further: the feed raw materials comprise wheat bran, DDGS and corn steep liquor.
Compared with the prior art, the invention has the advantages and technical effects that:
the invention takes aldehyde ketone reductase (WP_ 158815623.1) from methyl capsule a sp as basic raw material to mutate and improve, and a mutant AkrH with obviously improved effect on vomitoxin degradation is obtained by screening, and the mutation site is Q64D/L131S/L212V. Compared with the original gene, the degradation level of the mutant AkrH obtained by the invention on vomitoxin is improved by about 3 times.
According to the invention, the degradation agent prepared by carrying out compound treatment on the fermented liquid obtained by fermenting recombinant bacteria containing the aldehyde ketone reductase mutant AkrH, the spray-dried powder obtained after spray drying, the adsorbent such as eucommia ulmoides leaf extract, montmorillonite powder and the like can degrade vomitoxin in feed raw materials, and the degradation rate can reach more than 95% on average. Therefore, the aldehyde ketone reductase mutant AkrH and the degradation agent thereof can obviously degrade vomitoxin, reduce toxin pollution, have good application prospects in the fields of preventing mycotoxin, food, feed additives and the like, and are beneficial to animal cultivation.
Drawings
FIG. 1 shows the amplification result of the aldehyde-ketone reductase gene.
FIG. 2 is the effect of the aldehyde ketone reductase mutant on the degradation of vomitoxin.
FIG. 3 shows the results of 30L fermentation of the aldehyde ketoreductase mutant.
FIG. 4 shows the effect of degrading vomitoxin after the aldehyde ketone reductase mutant broth and montmorillonite are compounded.
Detailed Description
The present invention will be described more fully hereinafter with reference to the accompanying drawings and examples, in which the invention is shown, but the scope of the invention is not limited to the specific examples.
The molecular biology experimental methods not specifically described in the following examples can be performed with reference to the specific methods listed in the "molecular cloning Experimental guidelines (third edition) J.Sam Brookfield, or according to the kit and product instructions. Reagents and biological materials used in the specific examples are commercially available unless otherwise specified.
1. The formula of the culture medium used in the invention is as follows:
LB medium: 1% tryptone, 0.5% yeast extract, 1% nacl;
trichoderma reesei conversion medium (g/L):
conversion of the upper layer: glucose 10g, mgS0 4 ·7H 2 O 1g,KH 2 PO 4 10g,(NH 4 ) 2 SO 4 6g, sodium citrate 3g, feSO 4 ·7H 2 O 0.005g,MnSO 4 ·H 2 O 0.0016g,ZnSO 4 ·7H 2 O 0.0014g,CoCl 2 ·2H 2 0.002g of O, 182.18g of sorbitol, 6g of agarose and sterilizing for 30min at 115 ℃;
the lower layer was transformed: glucose 10g, mgS0 4 ·7H 2 O 1g,KH 2 PO 4 10g,(NH 4 ) 2 SO 4 6g, sodium citrate 3g, feSO 4 ·7H 2 O 0.005g,MnSO 4 ·H 2 O 0.0016g,ZnSO 4 ·7H 2 O 0.0014g,CoCl 2 ·2H 2 0.002g of O, 12g of agar powder and sterilizing for 30min at 115 ℃.
In the above culture medium, 10mM uracil was added to culture uracil-deficient cells.
PDA medium: 20% of potato extract and 2% of glucose.
MM medium: glucose 20g, mgS0 4 ·7H 2 O 0.6g,CaCl 2 0.6g,KH 2 PO 4 15g,
(NH 4 ) 2 SO 4 5g,Peptone 2g,FeSO 4 ·7H 2 O 0.005g,MnSO 4 ·H 2 O 0.0016g,ZnSO 4 ·7H 2 O0.0014g,CoCl 2 ·2H 2 O 0.002g。
Fermentation medium: 1-3% of soybean meal, 1000U/g of neutral protease, 3-5% of glucose, 0.1-0.5% of ammonium sulfate, 0.01-0.1% of magnesium sulfate, 0.01-0.1% of calcium chloride, 0.2-0.8% of potassium dihydrogen phosphate, 0.02-0.05% of tween and 3-10% of corn steep liquor.
2. Conversion-related reagents:
solution 1 (200 mL): 43.72g of sorbitol, 2.72g of potassium dihydrogen phosphate and adjusting the pH to 5.5 with sodium hydroxide solution.
Solution 2 (100 mL): sorbitol 18.22g, calcium chloride dihydrate 0.730 g,10mM Tris-HCl, pH 7.48.
Solution 3 (100 mL): PEG6000 25g, calcium chloride dihydrate 0.730 g,10mM Tris-HCl pH adjusted to 7.5.
3. Vomitoxin assay kit was purchased from Beijing Hua' an Mytilidae biotechnology Co., ltd, and was prepared according to the assay method described in the specification.
4. Trichoderma reesei conversion method
(1) Experiment preparation: PDA plate, sterile physiological saline (0.9% sodium chloride, 0.05% Tween-20), funnel with four layers of mirror cleaning paper or filter paper (sterilized), and glassine paper, cutting glassine paper into culture dish, placing one filter paper in the middle of each layer, placing in culture dish, and sterilizing.
(2) Culturing the bacterial cells: QP4 spores are taken on a plate of PDA (containing uracil) and cultured at 30 ℃ until the spores are grown; taking fresh spores, adding 5ml of sterile physiological saline, and washing out the spores to obtain spore suspension; a layer of cellophane was applied to a PDA (uracil containing) plate and spread with a spreading bar, 100ul of spore suspension was applied to the cellophane, spread evenly, and incubated at 30℃until more hyphae developed.
(3) Protoplast preparation and transformation: taking a clean plate, adding 0.1g of lyase, adding 20mL of solution 1, and uniformly mixing; washing the cultured mycelium into a plate containing lyase, and performing cleavage for 90 minutes at 30 ℃; after lysis, the mycelium is filtered by a funnel containing filter paper (mirror paper), and protoplasts are collected by centrifugation; resuspension with 4mL of solution 2, centrifugation at 2500rpm at 4 ℃ for 10min, discarding supernatant; sub-packaging after re-suspending with solution 2, adding 15ul of transformed plasmid into each tube, and ice-bathing for 5 min; then 2mL of solution 3 and 4mL of solution 2 are added respectively, and 30mL of transformation upper layer is added to the plate; culturing at 30 deg.C until the transformant grows.
Example 1: construction and screening of aldehyde ketone reductase mutant gene
Referring to the amino acid sequence of aldehyde ketone reductase (WP_ 158815623.1) of methyl capsule a sp, translating into a corresponding nucleotide sequence, and artificially synthesizing the amino acid sequence after gene sequence optimization, wherein the obtained amino acid sequence is shown as SEQ ID NO:1, the nucleotide sequence is shown as SEQ ID NO: 2. Primers were designed with BamHI restriction sites at the 5 'end and Sal I restriction sites at the 3' end.
Akr-F1:CGCGGATCCATGACAAAACCTACAGCTGC(SEQ ID NO:5)
Akr-R1:ACGCGTCGACTTATTTAGGACGAGCTTGAGCAT(SEQ ID NO:6)。
The random mutation is carried out by using the GeneMorph II random mutation PCR kit and using the artificially synthesized gene as a template and the primers, and the PCR amplification result is shown in figure 1.
The amplified random mutation PCR product is digested with BamHI and SalI, purified and recovered, and then connected to a pWB980 carrier, and positive clones are screened by referring to a bacillus subtilis transformation method created by Spizizin, bacillus subtilis WB600 is transformed and kanamycin-resistant LB plates, so that pAkrx is obtained. The synthesized original gene was ligated into the pWB980 vector in the same manner and transformed into Bacillus subtilis to give pAkr0.
The screened single colonies were inoculated into 96-well deep well plates. 2 single colonies expressing pAkr0 were inoculated per plate as controls. Each well was filled with 300uL of LB liquid medium (containing 20. Mu.g/mL kanamycin), and after shaking culture at 37℃and 200rpm for 12 hours, 50uL of the bacterial liquid was transferred to a new 96-well plate for seed preservation, and the effect of vomitoxin degradation was measured in the remaining bacterial liquid of the plate. Screening out mutants with degradation effect higher than that of a control group, and carrying out sequencing analysis to obtain an aldehyde ketone reductase mutant AkrH, wherein the amino acid sequence of the aldehyde ketone reductase mutant AkrH is shown as SEQ ID NO:3, the corresponding nucleotide sequence is shown as SEQ ID NO:4, the mutation site is Q64D/L131S/L212V.
Example 2: verification of the expression of Aldone reductase mutant AkrH in Trichoderma reesei
The excellent mutant AkrH obtained by screening in example 1 was amplified using the following primers Akr-F2 and Akr-R2, cloned into the Nco I and Sac I sites of plasmid pCBH, and transformed into Trichoderma reesei QP4 according to the genetic transformation method of Trichoderma reesei to obtain recombinant bacteria. And (3) carrying out shake flask fermentation on the recombinant bacteria in a fermentation medium at 30 ℃ for 4-5 days, and centrifuging the culture solution to obtain a supernatant for later use.
Akr-F2:CATGCCATGGATGACAAAACCTACAGCTGC(SEQ ID NO:7);
Akr-R2:CGAGCTCTTATTTAGGACGAGCTTGAGCAT(SEQ ID NO:8)。
According to the determination method in the kit, the supernatant after the fermentation liquor is centrifuged is taken, and the degradation activity of each mutant fermentation liquor supernatant on vomitoxin is determined, and the result is shown in figure 2, the degradation effect of mutant AkrH recombinant bacteria on vomitoxin is about 3 times that of a control group, and the degradation rate is increased from 25.5% to 75%.
Example 3: akrH recombinant bacteria are fermented and prepared in a 30L fermentation tank
The AkrH recombinant bacteria are streaked on a PDA plate, cultured at 30 ℃ until the spores are generated, the spores are cultured for about 7 days, the spores are washed out by sterile water, and monospore separation is carried out, namely, the spores are diluted and coated into MM culture medium (containing Triton-X100) until the colonies grow out, then the spores are cultured, and the third-generation pure seeds are separated. The pure spores were washed with 100mL of sterile water and used as seed solution for inoculating the fermenter.
The fermentation production process comprises the following steps: the fermentation medium has natural pH, 30 ℃, stirring speed of 600rpm and ventilation rate of 1.5 (v/v), and dissolved oxygen is controlled to be more than 20%. After 24h fermentation, the enzyme activity is measured, and after the fermentation is finished (generally 48 h), the fermentation broth is used for application test.
The fermentation process curve is shown in fig. 3: sampling every 8h, measuring enzyme production level, fermenting for 48h, and reaching the highest enzyme activity level.
Example 4: preparation and application of degradation agent containing AkrH
1. Preparation of degradation agent
After the AkrH recombinant bacterium fermentation broth of example 3 was centrifuged, a supernatant was obtained and spray-dried to obtain AkrH spray-dried powder. By weight, 10% of montmorillonite powder, 1.5% of glucose oxidase, 1% of bacillus subtilis, 22% of eucommia ulmoides leaf extract and 65.5% of AkrH spray-dried powder are uniformly mixed to prepare the degradation agent, and the degradation agent is used according to the dosage of 0.1-0.5%.
2. Application of degradation agent
(1) The degradation agent degrades wheat bran:
weighing 20g of wheat bran, adding 20mL of water, then adding 0.1g of degradation agent, and vibrating at 37 ℃ for different times to detect the residual content of vomitoxin by a kit method.
(2) Degradation agent degradation DDGS (distillers dried grains with solubles):
weighing 20g of raw material (DDGS), adding 0.1g of degradation agent, adjusting pH to 8.0 with buffer solution, treating at 37deg.C for different times, and detecting the residual content of vomitoxin by using the kit method.
(3) Degradation agent degrading corn steep liquor:
weighing 20mL of corn steep liquor, adding 0.1g of degradation agent, adjusting pH to 8.0 with buffer solution, treating at 37 ℃ for different time, and detecting the residual content of vomitoxin by a kit method.
As shown in the figure 4, the degradation agent is used for treating wheat bran for 5 hours, the vomitoxin degradation rate is 75%, and the vomitoxin degradation rate reaches 96.5% after the treatment is continued for 5 hours; after DDGS is treated for 5 hours, the degradation rate of vomitoxin is 55%, the treatment is continued for 5 hours, the degradation rate is increased to 80%, and after the treatment is carried out for 15 hours, the degradation rate reaches 94.7%; corn steep liquor was treated for 5h and 10h at 59% and 94.5%, respectively. The results show that the degradation agent has remarkable effect of degrading vomitoxin in different feed raw materials.
The above embodiments are only for illustrating the technical solution of the present invention, and are not limiting; although the invention has been described in detail with reference to the foregoing embodiments, it will be apparent to one skilled in the art that modifications may be made to the technical solutions described in the foregoing embodiments, or equivalents may be substituted for some of the technical features thereof; such modifications and substitutions do not depart from the spirit and scope of the corresponding technical solutions.
Claims (10)
1. An aldehyde ketone reductase mutant AkrH, characterized in that the amino acid sequence is as shown in SEQ ID NO: 3.
2. The aldehyde ketone reductase mutant AkrH according to claim 1, characterized in that it consists of an amino acid sequence of SEQ ID NO:1, from which glutamine at position 64 of the aldehyde-ketone reductase was changed to aspartic acid, leucine at position 131 was changed to serine, and leucine at position 212 was changed to valine.
3. The aldehyde ketone reductase mutant AkrH encoding gene of claim 1, having a nucleotide sequence as set forth in SEQ ID NO: 4.
4. A recombinant expression vector comprising the coding gene of claim 3.
5. A recombinant bacterium comprising the coding gene of claim 3, wherein the recombinant bacterium is bacillus subtilis, trichoderma reesei, or pichia pastoris.
6. A degradation agent, characterized in that the degradation agent comprises the aldehyde ketone reductase mutant AkrH, eucommia ulmoides leaf extract, montmorillonite powder, glucose oxidase and bacillus subtilis according to claim 1.
7. The degradation agent according to claim 6, wherein the degradation agent comprises 55% -70% of aldehyde ketone reductase mutant AkrH,8% -10% of montmorillonite powder, 0.1% -3% of glucose oxidase, 1% -3% of bacillus subtilis and the balance of eucommia ulmoides leaf extract by weight.
8. Use of the degradation agent of claim 6 for degrading vomitoxin in feed stocks.
9. The use according to claim 8, wherein the degradation agent is used in an amount of 0.1% -0.5% by weight of the feed material.
10. The use according to claim 8, wherein the feed stock comprises wheat bran, DDGS and corn steep liquor.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211721650.6A CN116042558A (en) | 2022-12-30 | 2022-12-30 | Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211721650.6A CN116042558A (en) | 2022-12-30 | 2022-12-30 | Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116042558A true CN116042558A (en) | 2023-05-02 |
Family
ID=86132441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211721650.6A Pending CN116042558A (en) | 2022-12-30 | 2022-12-30 | Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116042558A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170020138A1 (en) * | 2013-06-26 | 2017-01-26 | Symbiota, Inc. | Agricultural endophyte-plant compositions, and methods of use |
CN107916266A (en) * | 2017-12-05 | 2018-04-17 | 华中农业大学 | Fusarium toxin detoxification path related gene ADH, AKR6D1, AKR13B2 and its application |
CN109251933A (en) * | 2017-07-13 | 2019-01-22 | 华中农业大学 | A kind of and fusarium toxin and toxic aldehydes detoxification related gene AKR18A1 and its application |
CN115505580A (en) * | 2022-04-01 | 2022-12-23 | 华南农业大学 | Sorbose dehydrogenase for degrading vomitoxin and mutant thereof |
-
2022
- 2022-12-30 CN CN202211721650.6A patent/CN116042558A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170020138A1 (en) * | 2013-06-26 | 2017-01-26 | Symbiota, Inc. | Agricultural endophyte-plant compositions, and methods of use |
CN109251933A (en) * | 2017-07-13 | 2019-01-22 | 华中农业大学 | A kind of and fusarium toxin and toxic aldehydes detoxification related gene AKR18A1 and its application |
CN107916266A (en) * | 2017-12-05 | 2018-04-17 | 华中农业大学 | Fusarium toxin detoxification path related gene ADH, AKR6D1, AKR13B2 and its application |
CN115505580A (en) * | 2022-04-01 | 2022-12-23 | 华南农业大学 | Sorbose dehydrogenase for degrading vomitoxin and mutant thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113801832A (en) | Bacillus subtilis capable of producing psicose epimerase in high yield and application of bacillus subtilis | |
CN110042072B (en) | Aflatoxin B degradation1And application thereof | |
CN111172058A (en) | Bacillus amyloliquefaciens and application thereof | |
CN110607251A (en) | Salt-tolerant marinobacter capable of degrading vomitoxin and application thereof | |
CN102115720B (en) | Pediococcus acidilactici strain and method for producing pediocin by using same | |
JP4903129B2 (en) | Thermostable yeast strain | |
CN116042558A (en) | Degradation agent containing aldehyde ketone reductase mutant and eucommia ulmoides leaf extract and application thereof | |
CN114107113B (en) | Method for reducing ethyl carbamate in fermented food by using synthetic starter | |
JP2000037196A (en) | Ammonia-resistant l(+)-lactic acid productive bacterium and production of l(+)-lactic acid | |
WO2007010855A1 (en) | Method for fermentative production of n-acetyl-d-glucosamine by microorganism | |
CN114480205B (en) | Bacillus amyloliquefaciens and application thereof in brewing of solid-state fermentation vinegar | |
EA037039B1 (en) | Strain of heterotrophic bacterium klebsiella pneumonia 1-17, associate for producing microbial protein mass | |
CN113897319A (en) | Bacillus amyloliquefaciens and application thereof | |
CN115074347A (en) | Feed additive containing keratinase mutant and bile acid and application thereof | |
CN113337417A (en) | Agrobacterium capable of efficiently degrading ethyl carbamate and application thereof | |
CN113583896A (en) | Enterobacter huoshanense and application thereof | |
CN113249276A (en) | Bacillus cereus and application thereof | |
CN113174342A (en) | Strain for efficiently degrading ethyl carbamate and application thereof | |
CN1260004A (en) | Strain producing remarkable amount of epsilon-poly-L-Lysine and process for producing same | |
CN102174439A (en) | Marine halomonas for producing low-temperature beta-galactosidase and application thereof | |
CN111011707A (en) | Preparation method of flavor detoxified corn steep liquor | |
JP5926818B2 (en) | Cell killing method using polyethylene glycol nonionic surfactant | |
CN116286557B (en) | Salt-tolerant bacillus beijerinckii for producing cellulase and culture method thereof | |
CN112646854B (en) | Echinocandin B synthetic medium and application | |
CN112300954B (en) | Bacillus amyloliquefaciens and application thereof in fermentation production of glutaminase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: No. 9 Yanying North Road, Yanbei Street Office, Qihe County, Dezhou City, Shandong Province, 253000 Applicant after: Shandong Longchang Animal Health Products Co.,Ltd. Address before: 251100 No.1, North Park Road, Qihe Economic Development Zone, Dezhou City, Shandong Province Applicant before: SHANDONG LONGCHANG ANIMAL HEALTH PRODUCT Co.,Ltd. |
|
CB02 | Change of applicant information |